U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. 2024 Compounding Quality Center of Excellence Annual Conference - 08/21/2024
  1. News & Events for Human Drugs

Conference | Mixed

Event Title
2024 Compounding Quality Center of Excellence Annual Conference
August 21 - 23, 2024

Learning and Collaborating: Driving Toward the Future of Quality


Date:
August 21 - 23, 2024
Day1:
Wed, Aug 21
Day2:
Thu, Aug 22
Day3:
Fri, Aug 23

Our 2024 conference convened stakeholders from across the compounding industry to discuss emerging trends and best practices through presentations, panels, and interactive sessions. It included In-depth sessions on current good manufacturing (CGMP) topics and leveraging knowledge and building partnerships for the future. Links to recorded videos with captions are available in the table below.

2024 Conference Agenda

Watch the recorded sessionDescription

Pre-conference session – Developing a New Outsourcing Facility: Lessons Learned

Time: 2:37:04

Learn from established outsourcing facility leaders about the challenges of forming a new outsourcing facility and keys for success. Perspectives will include a hospital system-owned outsourcing facility, a 503A pharmacy that transitioned to an outsourcing facility, an outsourcing facility developed within a pharmaceutical company, and an outsourcing facility formed as a start-up. A panel discussion will share experiences interacting with newly formed outsourcing facilities.

Welcome and Opening Remarks

Time: 14:45

Day 1 Welcome and Opening Remarks

Opening Plenary – Learning and Growth: Successes and Challenges of a Developing Industry

Time: 1:15:43

This session explores the evolution of the outsourcing facility industry, including quality and factors influencing long-term viability.

The Business Case for Quality and Resilience

Time: 1:02:50

Panelists discuss perspectives from outsourcing facilities and customers on the benefits of investing in quality and resilience.

Session 1a

Risk Assessment in Aseptic Processing

Time: 58:45

Learn risk assessment tools for assessing aseptic processing operations that leverage technologies to increase sterility assurance.

Session 1b

Investigating Environmental Monitoring Excursions

Time: 54:58

Analyze an investigation of an environmental monitoring excursion highlighting critical aspects, such as microbiology and risk evaluation of the facility.

Session 1c

Visual Inspection

Time: 1:00:57

Learn the importance of visual inspection and review basic concepts illustrated with case studies.

Session 1d

Testing: Industry Perspectives

Time: 57:26

Explore the advantages and disadvantages of utilizing internal vs. external testing. Examine processes for handling out-of-specification and out-of-trend results.

Pediatric Considerations for Outsourcing Facilities

Time: 1:12:54

Discover how outsourcing facilities can be well positioned to meet many of the unique needs of children’s hospitals. Learn how collaboration can ensure pediatric access, quality, and safety.

Assessing Quality

Time: 59:25

Gain exposure to strategies and cases studies for internally assessing quality and the state of control within the framework of section 503B and CGMP.

Session 2a

Reframing Perspectives via CGMP Training

Time: 1:01:40

Gain understanding about how the training provided in pharmacy and other industries may not align with CGMP thinking. Learn how to align the thinking across the disciplines.

Session 2b

Data Integrity

Time: 57:30

Gain understanding about how the training provided in pharmacy and other industries may not align with CGMP thinking. Learn how to align the thinking across the disciplines.

Session 2c

Navigating State Laws and Regulations

Time: 1:02:15

Learn about variable state laws and regulations. Get updates on the latest potential state requirements and trends as they pertain to outsourcing facilities.

Session 2d

Contamination in Control Operations

Time: 59:45

Review contamination control practices for aseptic processing. Consider concepts and strategies for cleaning and disinfection of classified areas, disinfectant efficacy testing, commodity and component packaging, material transfer, and residue mitigation.

Session 3a

Developing an Effective Training Program

Time: 1:03:48

Learn strategies for developing an effective training program, such as implementation, methodologies, retraining, and connecting initial training to daily work activities.

Session 3b

Not Just Blowing Smoke: Why Smoke Studies are Critical

Time: 59:49

Explore the concept of airflow visualization and critical considerations to ensure an optimum smoke study. Examine standards, regulations, and guidance for airflow visualization, as well as examples demonstrating poor airflow and good airflow.

Session 3c

The Role of the Pharmacist in the Realm of Outsourcing Facilities

Time: 1:03:54

 

Explore the role of the pharmacist in the context of outsourcing facilities and health system pharmacies that interact with outsourcing facilities.

Session 3d

Automation: Environment and Facility Considerations

Time: 1:03:14

Discover the advantages of incorporating restrictive access barrier (RABs) into aseptic processing operations and when it makes sense to incorporate RABs into a facility. Consider facility design, environmental controls, and aseptic practices considerations.

Impact of Compliance on Product and Patient

Time: 1:00:06

Explore the differences and interplay between quality and compliance. Learn from examples that illustrate the impact of non-compliance on the product and patient.

Excipient Quality

Time: 44:16

Get an overview of excipients within the context of sterile compounding and understand the importance of excipient quality.

Sustaining and Building the Future of Quality Across Networks

Time: 50:15

Learn about tools available to outsourcing facilities and how to leverage knowledge and create partnerships for the future.

Closing Remarks

Time: 6:12

 
Back to Top